Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Danaher Corp
(NY:
DHR
)
268.79
-1.24 (-0.46%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Danaher Corp
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Looking Into Danaher's Recent Short Interest
October 04, 2024
Via
Benzinga
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
October 03, 2024
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst
October 01, 2024
Stifel analyst Jacob Johnson says Danaher is poised for a gradual recovery in 2025 and could generate high-single-digit growth.
Via
Benzinga
DANAHER CORP (NYSE:DHR) can be considered a quality stock. Here's why.
October 01, 2024
Why Quality Investors May Find DANAHER CORP (NYSE:DHR) Attractive.
Via
Chartmill
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
September 27, 2024
Via
Benzinga
Spotlight on Danaher: Analyzing the Surge in Options Activity
September 26, 2024
Via
Benzinga
Danaher Unusual Options Activity
September 23, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Danaher
September 09, 2024
Via
Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
September 06, 2024
Via
Benzinga
Momentum Investing Gives You An Edge, Until It Doesn’t
September 17, 2024
Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system.
Via
Talk Markets
Smart Money Is Betting Big In DHR Options
September 05, 2024
Via
Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today
August 26, 2024
Via
Benzinga
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
August 08, 2024
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks Whale Activity In Today's Session
August 08, 2024
Via
Benzinga
Behind the Scenes of Danaher's Latest Options Trends
August 05, 2024
Via
Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
August 02, 2024
Via
Benzinga
(DHR) - Analyzing Danaher's Short Interest
August 01, 2024
Via
Benzinga
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
July 30, 2024
Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks."
Via
Benzinga
Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
July 28, 2024
11 large-cap stocks saw significant gains in the last week, driven by positive earnings and guidance updates. Check if they're in your portfolio.
Via
Benzinga
Top Stock Reports For Costco, Danaher & ServiceNow
July 27, 2024
Today's Research Daily features new research reports on 16 major stocks, including Costco, Danaher Corporation and ServiceNow, as well as two micro-cap stocks AMREP Corporation and Autoscope...
Via
Talk Markets
It's Time for Some Enthusiasm for Small-Cap Stocks
July 26, 2024
After a year and a half of big names pushing the market forward, some smaller companies are starting to go on a run.
Via
The Motley Fool
Demystifying Danaher: Insights From 5 Analyst Reviews
July 24, 2024
Via
Benzinga
Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
July 26, 2024
Freeport-McMoRan is Bryn Talkington's "final trade." On July 23, Freeport-McMoRan said second-quarter revenue came in at $6.62 billion.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 23, 2024
Via
Benzinga
Here's Why Danaher Stock Surged Today
July 23, 2024
The biotechnology, diagnostics, and life sciences company looks set to return to its long-term growth rate.
Via
The Motley Fool
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
July 23, 2024
Via
Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 23, 2024
Via
Benzinga
DHR Stock Earnings: Danaher Beats EPS, Beats Revenue for Q2 2024
July 23, 2024
DHR stock results show that Danaher beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Medical Giant Danaher Nears Breakout On This 'Stark Contrast' With A Key Rival
July 23, 2024
The company kept its outlook for the year, which differs from Sartorius' cut last week.
Via
Investor's Business Daily
Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance
July 23, 2024
Danaher reported a 3% year-over-year decline in Q2 sales to $5.743 billion, surpassing the $5.59 billion consensus. Adjusted EPS was $1.72, beating expectations of $1.57. CEO Rainer Blair highlighted...
Via
Benzinga
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.